Jeffrey M. Sturek

Immune Checkpoint Inhibitor-Associated Pneumonitis in Patients Treated for Metastatic Renal Cell Carcinoma

Immune checkpoint inhibitors (ICIs) improve outcomes in metastatic renal cell carcinoma (mRCC) but may be associated with pneumonitis. We retrospectively studied adults with mRCC who began first- or second-line ICI therapy at the University of Virginia Medical Center between 2015...